17β-Estradiol and the phytoestrogen genistein attenuate neuronal apoptosis induced by the endoplasmic reticulum calcium-ATPase inhibitor thapsigargin

Steroids

Volumn 67, Issue 13-14, 2002, Pages 1029-1040

  Linford, Nancy J ^a   Dorsa, Daniel M ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Estrogen; Genistein; Neuroprotection; Phytoestrogen; Thapsigargin

Indexed keywords

ADENOSINE TRIPHOSPHATASE INHIBITOR; CASPASE 3; DNA FRAGMENT; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FULVESTRANT; GENISTEIN; PHYTOESTROGEN; THAPSIGARGIN; ADENOSINE TRIPHOSPHATASE (CALCIUM); CASP3 PROTEIN, RAT; CASPASE; ESTROGEN; ESTROGEN RECEPTOR; ISOFLAVONE DERIVATIVE; NEUROPROTECTIVE AGENT; PLANT MEDICINAL PRODUCT;

ANIMAL CELL; ANIMAL MODEL; APOPTOSIS; ARTICLE; BRAIN NERVE CELL; CELL COUNT; CELL FUNCTION; CELL LEVEL; CELL NUCLEUS; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACTIVITY; DRUG EFFECT; ENZYME ACTIVATION; ENZYME ACTIVITY; MITOCHONDRION; NEUROPROTECTION; NEWBORN; NONHUMAN; PROTEIN EXPRESSION; RAT; ANIMAL; CYTOLOGY; DOSE RESPONSE; DRUG ANTAGONISM; ENZYMOLOGY; METABOLISM; NERVE CELL; POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CALCIUM-TRANSPORTING ATPASES; CASPASE 3; CASPASES; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; ESTROGENS, NON-STEROIDAL; GENISTEIN; ISOFLAVONES; NEURONS; NEUROPROTECTIVE AGENTS; PHYTOESTROGENS; PLANT PREPARATIONS; POLYMERASE CHAIN REACTION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ESTROGEN; THAPSIGARGIN;

EID: 0036889192     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-128X(02)00062-4     Document Type: Article

References (70)

1. Thompson C.B. Apoptosis in the pathogenesis and treatment of disease. Science. 267(5203):1995;1456-1462.
2. Sastry P.S., Rao K.S. Apoptosis and the nervous system. J. Neurochem. 74(1):2000;1-20.
3. Robertson G.S., Crocker S.J., Nicholson D.W., Schulz J.B. Neuroprotection by the inhibition of apoptosis. Brain Pathol. 10(2):2000;283-292.
4. Porter A.G., Janicke R.U. Emerging roles of caspase-3 in apoptosis. Cell Death Differ. 6(2):1999;99-104.
5. Zipfel G.J., Babcock D.J., Lee J.M., Choi D.W. Neuronal apoptosis after CNS injury: the roles of glutamate and calcium. J. Neurotrauma. 17(10):2000;857-869.
6. White B.C., Sullivan J.M., DeGracia D.J., O'Neil B.J., Neumar R.W., Grossman L.I.et al. Brain ischemia and reperfusion: molecular mechanisms of neuronal injury. J. Neurol. Sci. 179(S1/2):2000;1-33.
7. Paschen W., Doutheil J. Disturbance of endoplasmic reticulum functions: a key mechanism underlying cell damage? Acta. Neurochir. Suppl. 73:1999;1-5.
8. Blackshaw S., Sawa A., Sharp A.H., Ross C.A., Snyder S.H., Khan A.A. Type 3 inositol 1,4,5-trisphosphate receptor modulates cell death. FASEB J. 14(10):2000;1375-1379.
9. Zhang L., Andou Y., Masuda S., Mitani A., Kataoka K. Dantrolene protects against ischemic, delayed neuronal death in gerbil brain. Neurosci. Lett. 158(1):1993;105-108.
10. Frandsen A., Schousboe A. Mobilization of dantrolene-sensitive intracellular calcium pools is involved in the cytotoxicity induced by quisqualate and N-methyl-D-aspartate but not by 2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl) propionate and kainate in cultured cerebral cortical neurons. Proc. Natl. Acad. Sci. U.S.A. 89(7):1992;2590-2594.
11. Arai Y., Sekine Y., Murakami S. Estrogen and apoptosis in the developing sexually dimorphic preoptic area in female rats. Neurosci. Res. 25(4):1996;403-407.
12. Miranda R.C., Sohrabji F., Toran-Allerand D. Interactions of estrogen with the neurotrophins and their receptors during neural development. Horm. Behav. 28(4):1994;367-375.
13. van Duijn C.M. Hormone replacement therapy and Alzheimer's disease. Maturitas. 31(3):1999;201-205.
14. Simpkins J.W., Green P.S., Gridley K.E., Singh M., de Fiebre N.C., Rajakumar G. Role of estrogen replacement therapy in memory enhancement and the prevention of neuronal loss associated with Alzheimer's disease. Am. J. Med. 103(3A):1997;19S-25S.
15. McEwen B.S., Alves S.E. Estrogen actions in the central nervous system. Endocr. Rev. 20(3):1999;279-307.
16. Dubal D.B., Kashon M.L., Pettigrew L.C., Ren J.M., Finklestein S.P., Rau S.W.et al. Estradiol protects against ischemic injury. J. Cereb. Blood Flow Metab. 18(11):1998;1253-1258.
17. Gridley K.E., Green P.S., Simpkins J.W. Low concentrations of estradiol reduce beta-amyloid (25-35)-induced toxicity, lipid peroxidation and glucose utilization in human SK-N-SH neuroblastoma cells. Brain Res. 778(1):1997;158-165.
18. Singer C.A., Rogers K.L., Strickland T.M., Dorsa D.M. Estrogen protects primary cortical neurons from glutamate toxicity. Neurosci. Lett. 212(1):1996;13-16.
19. Toung T.J., Traystman R.J., Hurn P.D. Estrogen-mediated neuroprotection after experimental stroke in male rats. Stroke. 29(8):1998;1666-1670.
20. Gapstur S.M., Morrow M., Sellers T.A. Hormone replacement therapy and risk of breast cancer with a favorable histology: results of the Iowa Women's Health Study [see comments]. JAMA. 281(22):1999;2091-2097.
21. Colditz G.A. Hormones and breast cancer: evidence and implications for consideration of risks and benefits of hormone replacement therapy. J. Womens Health. 8(3):1999;347-357.
22. Martin P.M., Horwitz K.B., Ryan D.S., McGuire W.L. Phytoestrogen interaction with estrogen receptors in human breast cancer cells. Endocrinology. 103(5):1978;1860-1867.
23. Zava D.T., Blen M., Duwe G. Estrogenic activity of natural and synthetic estrogens in human breast cancer cells in culture. Environ. Health Perspect. 105(Suppl. 3):1997;637-645.
24. Makela S., Savolainen H., Aavik E., Myllarniemi M., Strauss L., Taskinen E.et al. Differentiation between vasculoprotective and uterotrophic effects of ligands with different binding affinities to estrogen receptors alpha and beta. Proc. Natl. Acad. Sci. U.S.A. 96(12):1999;7077-7082.
25. Diel P., Olff S., Schmidt S., Michna H. Molecular identification of potential selective estrogen receptor modulator (SERM) like properties of phytoestrogens in the human breast cancer line MCF-7. Planta Med. 67(6):2001;510-514.
26. Kuiper G.G., Lemmen J.G., Carlsson B., Corton J.C., Safe S.H., van der Saag P.T.et al. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology. 139(10):1998;4252-4263.
27. Gridley K.E., Green P.S., Simpkins J.W. A novel, synergistic interaction between 17 beta-estradiol and glutathione in the protection of neurons against beta-amyloid 25-35-induced toxicity in vitro. Mol. Pharmacol. 54(5):1998;874-880.
28. Sawada H., Shimohama S. Neuroprotective effects of estradiol in mesencephalic dopaminergic neurons. Neurosci. Biobehav. Rev. 24(1):2000;143-147.
29. MacManus J.P., Rasquinha I., Black M.A., Laferriere N.B., Monette R., Walker T.et al. Glutamate-treated rat cortical neuronal cultures die in a way different from the classical apoptosis induced by staurosporine. Exp. Cell Res. 233(2):1997;310-320.
30. Dubal D.B., Shughrue P.J., Wilson M.E., Merchenthaler I., Wise P.M. Estradiol modulates bcl-2 in cerebral ischemia: a potential role for estrogen receptors. J. Neurosci. 19(15):1999;6385-6393.
31. Singer C.A., Figueroa-Masot X.A., Batchelor R.H., Dorsa D.M. The mitogen-activated protein kinase pathway mediates estrogen neuroprotection after glutamate toxicity in primary cortical neurons. J. Neurosci. 19(7):1999;2455-2463.
32. Honda K., Sawada H., Kihara T., Urushitani M., Nakamizo T., Akaike A.et al. Phosphatidylinositol 3-kinase mediates neuroprotection by estrogen in cultured cortical neurons. J. Neurosci. Res. 60(3):2000;321-327.
33. Panickar K.S., Guan G., King M.A., Rajakumar G., Simpkins J.W. 17Beta-estradiol attenuates CREB decline in the rat hippocampus following seizure. J. Neurobiol. 33(7):1997;961-967.
34. Green P.S., Gordon K., Simpkins J.W. Phenolic A ring requirement for the neuroprotective effects of steroids. J. Steroid Biochem. Mol. Biol. 63(4-6):1997;229-235.
35. Moosmann B., Behl C. The antioxidant neuroprotective effects of estrogens and phenolic compounds are independent from their estrogenic properties. Proc. Natl. Acad. Sci. U.S.A. 96(16):1999;8867-8872.
36. Brewer G.J., Torricelli J.R., Evege E.K., Price P.J. Optimized survival of hippocampal neurons in B27-supplemented neurobasal, a new serum-free medium combination. J. Neurosci. Res. 35(5):1993;567-576.
37. Yan X., Xiao R., Dou Y., Wang S., Qiao Z., Qiao J. Carbachol blocks beta-amyloid fragment 31-35-induced apoptosis in cultured cortical neurons. Brain Res. Bull. 51(6):2000;465-470.
38. Wade C., Robinson S., Shapiro R., Dorsa D.M. Estrogen receptor (ER) alpha and ER beta exhibit unique pharmacologic properties when coupled to activation of the mitogen-activated protein kinase pathway. Endocrinology. 142(6):2001;2336-2342.
39. Wei H., Wei W., Bredesen D.E., Perry D.C. Bcl-2 protects against apoptosis in neuronal cell line caused by thapsigargin-induced depletion of intracellular calcium stores. J. Neurochem. 70(6):1998;2305-2314.
40. Srivastava R.K., Sollott S.J., Khan L., Hansford R., Lakatta E.G., Longo D.L. Bcl-2 and Bcl-X(L) block thapsigargin-induced nitric oxide generation, c-Jun NH(2)-terminal kinase activity, and apoptosis. Mol. Cell Biol. 19(8):1999;5659-5674.
41. Arai Y., Uehara M., Sato Y., Kimira M., Eboshida A., Adlercreutz H.et al. Comparison of isoflavones among dietary intake, plasma concentration and urinary excretion for accurate estimation of phytoestrogen intake. J. Epidemiol. 10(2):2000;127-135.
42. Howell A., Osborne C.K., Morris C., Wakeling A.E. ICI 182,780 (Faslodex): development of a novel, "pure" antiestrogen. Cancer. 89(4):2000;817-825.
43. 2+ pool and induces apoptosis in human hepatoma cells. Cell Biol. Int. 17(10):1993;969-970.
44. Shughrue P.J., Lane M.V., Merchenthaler I. Comparative distribution of estrogen receptor-alpha and -beta mRNA in the rat central nervous system. J. Comp. Neurol. 388(4):1997;507-525.
45. Dubal D.B., Zhu H., Yu J., Rau S.W., Shughrue P.J., Merchenthaler I.I.et al. Estrogen receptor alpha, not beta, is a critical link in estradiol-mediated protection against brain injury. Proc. Natl. Acad. Sci. U.S.A. 98(4):2001;1952-1957.
46. Nilsen J., Mor G., Naftolin F. Estrogen-regulated developmental neuronal apoptosis is determined by estrogen receptor subtype and the Fas/Fas ligand system. J. Neurobiol. 43(1):2000;64-78.
47. Kim H., Bang O.Y., Jung M.W., Ha S.D., Hong H.S., Huh K.et al. Neuroprotective effects of estrogen against beta-amyloid toxicity are mediated by estrogen receptors in cultured neuronal cells. Neurosci. Lett. 302(1):2001;58-62.
48. Sampei K., Goto S., Alkayed N.J., Crain B.J., Korach K.S., Traystman R.J.et al. Stroke in estrogen receptor-alpha-deficient mice. Stroke. 31(3):2000;738-743. [discussion 44].
49. Wang L., Andersson S., Warner M., Gustafsson J.A. Morphological abnormalities in the brains of estrogen receptor beta knockout mice. Proc. Natl. Acad. Sci. U.S.A. 98(5):2001;2792-2796.
50. Perillo B., Sasso A., Abbondanza C., Palumbo G. 17beta-estradiol inhibits apoptosis in MCF-7 cells, inducing bcl-2 expression via two estrogen-responsive elements present in the coding sequence. Mol. Cell Biol. 20(8):2000;2890-2901.
51. Garcia-Segura L.M., Azcoitia I., DonCarlos L.L. Neuroprotection by estradiol. Prog. Neurobiol. 63(1):2001;29-60.
52. Harms C., Lautenschlager M., Bergk A., Katchanov J., Freyer D., Kapinya K.et al. Differential mechanisms of neuroprotection by 17beta-estradiol in apoptotic versus necrotic neurodegeneration. J. Neurosci. 21(8):2001;2600-2609.
53. Linford N.J., Yang Y., Cook D.G., Dorsa D.M. Neuronal apoptosis resulting from high doses of the isoflavone genistein: role for calcium and p42/44 mitogen-activated protein kinase. J. Pharmacol. Exp. Ther. 299(1):2001;67-75.
54. Wilson M.E., Dubal D.B., Wise P.M. Estradiol protects against injury-induced cell death in cortical explant cultures: a role for estrogen receptors. Brain Res. 873(2):2000;235-242.
55. Cohen G.M. Caspases: the executioners of apoptosis. Biochem. J. 326(Pt 1):1997;1-16.
56. Wang K.K. Calpain and caspase: can you tell the difference? Trends Neurosci. 23(1):2000;20-26.
57. Meda C., Vegeto E., Pollio G., Ciana P., Patrone C., Pellicciari C.et al. Oestrogen prevention of neural cell death correlates with decreased expression of mRNA for the pro-apoptotic protein nip-2. J. Neuroendocrinol. 12(11):2000;1051-1059.
58. Walton M., Woodgate A.M., Muravlev A., Xu R., During M.J., Dragunow M. CREB phosphorylation promotes nerve cell survival. J. Neurochem. 73(5):1999;1836-1842.
59. Xia Z., Dickens M., Raingeaud J., Davis R.J., Greenberg M.E. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science. 270(5240):1995;1326-1331.
60. Adams J.M., Cory S. The Bcl-2 protein family: arbiters of cell survival. Science. 281(5381):1998;1322-1326.
61. Behl C., Skutella T., Lezoualc'h F., Post A., Widmann M., Newton C.J.et al. Neuroprotection against oxidative stress by estrogens: structure-activity relationship. Mol. Pharmacol. 51(4):1997;535-541.
62. Howard S.A., Brooke S.M., Sapolsky R.M. Mechanisms of estrogenic protection against gp120-induced neurotoxicity. Exp. Neurol. 168(2):2001;385-391.
63. Zhou H., Li X.M., Meinkoth J., Pittman R.N. Akt regulates cell survival and apoptosis at a postmitochondrial level. J. Cell Biol. 151(3):2000;483-494.
64. Zhang Y., Tounekti O., Akerman B., Goodyer C.G., LeBlanc A. 17-beta estradiol induces an inhibitor of active caspases. J. Neurosci. 21(20):2001;1-6.
65. Li Y., Bhuiyan M., Sarkar F.H. Induction of apoptosis and inhibition of c-erbB-2 in MDA-MB-435 cells by genistein. Int. J. Oncol. 15(3):1999;525-533.
66. Linford NJ, Dorsa DM. The phytoestrogen genistein induces apoptosis in primary cortical neurons. In: Proceedings of the 30th Annual Meeting of the Society for Neuroscience, vol. 2. New Orleans, LA, 2000. p. 2091.
67. Faber K.A., Hughes C.L. Jr. Dose-response characteristics of neonatal exposure to genistein on pituitary responsiveness to gonadotropin releasing hormone and volume of the sexually dimorphic nucleus of the preoptic area (SDN-POA) in postpubertal castrated female rats. Reprod. Toxicol. 7(1):1993;35-39.
68. Flynn K.M., Ferguson S.A., Delclos K.B., Newbold R.R. Effects of genistein exposure on sexually dimorphic behaviors in rats. Toxicol. Sci. 55(2):2000;311-319.
69. Delclos K.B., Bucci T.J., Lomax L.G., Latendresse J.R., Warbritton A., Weis C.C.et al. Effects of dietary genistein exposure during development on male and female CD (Sprague-Dawley) rats. Reprod. Toxicol. 15(6):2001;647-663.
70. Newbold R.R., Banks E.P., Bullock B., Jefferson W.N. Uterine adenocarcinoma in mice treated neonatally with genistein. Cancer Res. 61(11):2001;4325-4328.